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Abstract
Treatments outside of a clinical setting may be managed independently by the pediatric patient, independently by a
caregiver, or by the patient and caregiver together. Best practices for pediatric clinical outcome assessment (COA)
recommend patient-reported outcome (PRO) and/or observer-reported outcome (ObsRO) measures to assess the
patient experience of a condition or its treatment. However, a dyad approach where patients and caregivers can complete
assessments together may be useful for assessing a shared treatment experience that may not be adequately captured by a
PRO and/or an ObsRO. A systematic, targeted literature review of empirical literature was conducted to identify and
describe published studies detailing dyad patient-caregiver outcome reporting approaches. The search was run in the
MEDLINE®, Embase, and PsycINFO® databases using the OvidSP platform and was limited to English-language
studies published within 10 years of the conducted search on 28 September 2021, and 13 articles were selected for fulltext review based on pre-specified criteria. Advantages and disadvantages for use of a dyad data collection approach are
discussed. Though not appropriate for all settings, dyad data collection may be useful for situations where the best
practice approach to measurement does not capture all relevant perspectives, or the use of PRO and ObsRO also does
not comprehensively capture all relevant concepts. In following, it may offer a pragmatic solution that can minimize the
use of proxy assessment and limit missing data, particularly in research involving a shared patient and caregiver treatment
experience.
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Introduction
Clinical outcome assessments (COAs) are used to measure
a wide range of outcomes including those associated with
treatments such as reduction in disease-related symptoms
and health-related quality of life impacts or the burden of
treatment on the lives of patients and caregivers. COA
strategies for children and adolescents may involve patient
self-report via patient-reported outcome (PRO) measures,
and informant reports through observer-reported outcome
(ObsRO) or proxy measures, depending on the ability of
the patients.1
PRO measures consist of questions answered by the
patient themselves about the status of their health
condition without interpretation of the response by an
observer such as a clinician or a caregiver.2 While PRO
measures are the most direct approach to collecting the
patient perspective, informant reports may be needed
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when a child or adolescent is unable to reliably self-report
(i.e., understand the question and independently select
responses) using a PRO measure and in these cases
ObsRO or proxy measures may be used (Figure 1).
ObsRO measures include questions answered by someone
other than the patient or clinician that require the
respondent to answer based on directly observed behavior
(what they have seen or heard, without interpretation or
inference).2 Proxy-reported outcome measures also include
questions answered by someone other than the patient,
but differ from ObsRO measures as they require the
respondent to make inferences about the patient’s
subjective experience.2 Proxy reports have been used
historically to obtain data in scenarios where patients may
not be able to provide input, and may provide useful data
from the caregiver perspective, but responses on these
measures can differ from PROs and the US Food and
Drug Administration (FDA) guidance in COA2,3
discourages the use of proxy-reported outcomes for any
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Figure 1. Reporting options suggested for the assessment of treatment administration experiences involving a
patient and caregiver
Single set of questions
with observable content
relevant to the experience
of treatment
administration

Question 1
Question 2
Question 3

Question 4

PRO (patient answers all questions independently)

Question 5
Question 6

Question 7
Question 8

ObsRO (caregiver answers all questions independently)
Dyad (patient and caregiver answer questions together)

Question 9
Question 10

age group, including children and adolescents. There are
reports in the literature that the expressed perceptions of a
child may differ in magnitude or importance from the
caregiver. Research has demonstrated better agreement
between child- and caregiver-report when the caregiver is
more directly involved in the care of the child4, 5 and when
events are directly observable by caregivers (e.g., physical
function, activities of daily living) compared to experiences
that are non-observable (e.g., symptom severity or
emotional impacts).
While PRO measures are the preferred approach to
assessing the breadth of the patient experience, best
practice guidelines1,2,6-9 recommend the use of ObsROs
when children are not able to independently complete a
PRO. ObsROs are limited to the assessment of observable
concepts, based on direct observations of the child or
what the child has said within a specified time period.1
While PROs and ObsROs are appropriate for assessing
direct and observable concepts from patients and
informants (e.g., caregivers), respectively, another
approach is needed to support the assessment of treatment
experiences that are shared by the child and caregiver.
This is particularly important as the level of involvement
that caregivers have in treatment administration may vary
from patient to patient based on a myriad of factors (e.g.,
age, experience, and cognitive ability).
Medicines administered outside of a clinical setting (i.e., at
home, school, camp, etc.) to children and adolescents may
involve varied routes of administration, including but not
limited to oral (solid or liquid), nasal, inhaled, rectal,
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cutaneous or transdermal, ear, eye, parenteral,
subcutaneous or intramuscular injection, or IV infusion.10
Given the range of administration options and varied
requirements in preparation and follow-up of these
treatments, there are contexts involving a shared
experience, in the management of a condition or its
treatment, that may not be adequately captured through
the administration of only a PRO and/or an ObsRO
measure. For example, when administering medicines at
home, there may be special considerations for regimen or
schedule, dosing and measuring devices to aid
administration, storage to support the optimal treatment
effect for the patient, and supervision post-administration
to monitor for side effects that require support from the
caregiver. Assessing all of these factors within a shared
treatment administration model can be challenging,
particularly if the patient and caregiver are sharing the
experience and responding to separate COA measures as
responses may conflict, or the approach taken by the
caregiver and the child may vary from administration to
administration.
This literature review explored a dyad approach to data
collection, wherein the child/adolescent and caregiver
provide input together on a COA measure in the context
of qualitative or quantitative data collection in instances
where a separate PRO or ObsRO would not fully capture
the treatment experience. Understanding the ways in
which dyad reports have been employed in qualitative and
quantitative research (for COA instrument development
and other purposes), including the advantages and
limitations of the approach, can provide useful
information for future applications.

Patient Experience Journal, Volume 9, Issue 2 – 2022

Review of pediatric-caregiver dyad data collection literature, Loftus et al.

Methods

The grey literature search was not restricted by publication
year (i.e., articles published more than 10 years prior to the
search were considered), though the same inclusion and
exclusion criteria described above for the targeted search
were applied.

A systematic and targeted review of empirical literature
was conducted to identify published studies detailing dyad
patient-caregiver outcome reporting approaches. A search
strategy was developed to identify abstracts for articles that
may provide additional details on the dyadic data
collection approach and the associated
advantages/disadvantages. More specifically, the search
strategy employed terms related to the dyad approach (e.g.,
dyad, dyadic, and shared decision), the parties involved in
dyadic data collection (e.g., patient, caregiver, and parent),
and the data collection method (e.g., PRO, questionnaire,
and interview).

Studies were excluded from full-text review if they focused
on shared decision-making or dyad discussions in other
contexts (e.g., treatment decision-making), or if study data
were collected from a patient and caregiver independent of
one another for comparative purposes. Studies that
utilized a dyad approach to data collection but did not
appear to provide additional commentary on the approach
were not considered for full-text review but were recorded
to better understand the frequency with which the dyad
approach has been utilized within the published literature.

The search was run in the MEDLINE®, Embase, and
PsycINFO® databases using the OvidSP platform and
was limited to English-language studies published within
10 years of the conducted search on 28 September 2021.
The resulting abstracts were screened using Abstrackr,11 a
web-based program used to screen abstracts and
document whether or not each abstract was relevant to the
research question (i.e., meets the study inclusion/exclusion
criteria).

Articles selected for full-text review were reviewed in full
and data related to the use of the dyad approach and the
author’s commentary on the approach were summarized.
The holistic results of the study summarize the identified
studies including the methodology employed, provide
commentary on the use of the dyad approach as reported
in prior studies, and highlight the advantages and
disadvantages of the dyad data collection approach.

Abstracts were considered for inclusion if they were
published in peer-reviewed journals and primarily focused
on the administration or application of a dyad approach to
data collection in a qualitative study or quantitative study
and appeared to provide commentary on the advantages
and disadvantages of the approach.

Results
Results of targeted search strategy and grey literature
search

The targeted search strategy yielded 932 abstracts. All
abstracts were reviewed, and ultimately three publications
were selected for full-text review that appeared to
primarily focus on a dyad data collection approach and the
associated benefits and disadvantages (Figure 2). An
additional 10 publications were identified via Google

In addition to the systematic search, a grey literature search
was conducted using Google, Google Scholar, and a
review of reference lists in selected articles to identify
additional literature related to the key research question.
Figure 2. Search flow diagram

Abstracts identified in MEDLINE®, PsychINFO, and Embase search
(n=932)

Articles selected for full-text review

Articles not meeting inclusion criteria

(n=3)

(n=929)

Additional articles identified via grey
literature search

Total articles included in final literature
analysis

(n=10)

(N=13)
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Scholar search, as well as through a review of reference
lists of selected publications, that met the study inclusion
and exclusion criteria. Thus, a total of 13 full-text articles
were included in the final analysis. Among these, 11
presented original research findings, one was a review
article, and one was a guidance document. Table 1

presents an overview of the 11 articles presenting original
research findings.
An additional 16 studies were identified that utilized a
shared dyad approach to data collection in qualitative
research (n=14 studies), quantitative COA data collection

Table 1. Overview of original research studies (n=11) included in review
Citation
Coutant et al.
2017
Eisikovits Z. and
Koren C. 2010

Research focus

Data
collection
method
Dyad
questionnaires
Dyad and
individual
interviews
Dyad
interviews and
focus groups

Patients
Age (years)
Sex n
Mean (min-max)
11.3 (1.1-18.1)
Male: 225
Female: 184
Not reported (66Not
92)
reported

Country

Sample
size n

France

409

Israel

40

U.S.

8

Not reported

Not
reported

Dyad
questionnaires

U.S.

133

12.4 (range not
reported)

Male: 91
Female: 45

Pediatric growth
disturbance
“Second
couplehood” in
old age
Growth
hormone
deficiency
(GHD)
GHD

Efficacy of
injection device
Effectiveness of
dyad interview
approach
Development of
dyad questionnaire
to assess injection
pen administration
Dyad perception
of injection device

Morris, SM 2001

Cancer (breast,
lung, colorectal,
lymphoma)

Effectiveness of
dyad interview
approach

Dyad and
individual
interviews

UK

Dyad: 19
Individual:
41

Dyads: 58 (26-76)
Individual: 57 (3283)

Dyads:
Male: 10
Female: 9
Individual:
Males: 10
Females: 18

Neveus T et al.
1999

Enuresis and
incontinence

Role of sleep on
nocturnal enuresis

Dyad
questionnaires

Sweden

1,413

7.9 (6.2-10.9)

Pleil et al. 2012

GHD

Dyad
questionnaires

U.S.

136

12.3 (range not
reported)

Taylor B. and de
Vochet H. 2011

Cancer, motor
neuron disease

Dyad and
individual
interviews

UK and
Netherlands

Not
reported

Not reported

Not
reported

Turner Bowker
DM et al. 2020

GHD

Dyad and
individual
interviews

U.S.

21
Adult: 6
Pediatric:
15

Adult: 47.9 (32-60)
Pediatric: 9.7 (4-15)

Ungar et al. 2006

Asthma

Dyad
interviews

Canada

16

10.7 (8-15)

Adult:
Male: 4
Female: 2
Pediatric:
Male: 11
Female: 4
Male: 9
Female: 7

Ungar et al. 2012

Asthma

Development and
psychometric
performance of
dyad questionnaire
to assess injection
pen administration
Experience of
sexuality and
intimacy living
with life-limiting
illness
Use of dyad
questionnaire to
assess human
growth hormone
injection
treatment burden
Ability of dyads to
assess Healthrelated quality of
life (HRQoL) in
children
Ability of dyads to
assess HRQoL in
children

n-value not
reported
Male: 49.3%
Female:
50.7%
Male: 91
Female: 45

Dyad
questionnaires

Canada

91

10.9 (8-17)

Etschmaier M. et
al. 2009
Hey-Hadavi et al.
2010

74

Target patient
population

Male: 50
Female: 41
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(n=1), and both qualitative shared dyad qualitative and
quantitative COA data collection (n=1); however, these
studies did not report details or advantages/disadvantages
of the method.

Dyad data collection in qualitative interview research

A growing body of literature describing the use of various
dyadic approaches in qualitative research has emerged over
the last few decades; in particular, for interview studies.
Eisikovits and Koren (2010)12 describe and compare the
advantages and disadvantages of several dyadic qualitative
interview approaches including separate interviews with
each member of the dyad, single interviews conducted
jointly with both dyad members, and a combined (i.e.,
separate and joint interview) approach.12 Eisikovits and
Koren (2010) suggest that the best quality data may be
collected through interviewing each dyad partner
separately, in order to capture each participant’s unique
perspective, and then use the dyad data (rather than
individual data) as the unit of analysis.12,13 Still, Eisikovits
and Koren (2010) also suggest that interviewing dyad
participants jointly can provide a unique third perspective
(i.e., the shared perspective of both dyad members) that is
not captured through discussion with each individual dyad
member and allows researchers to observe and analyze the
interactions between dyad members that may be
particularly helpful in some contexts (e.g., caregiver-patient
relationships).12,14 The authors also note that when the
goal of research is to compare and contrast the
perspectives of individuals within a dyad, separate
interviews with each individual may be ideal; one limitation
of this approach is that it only provides the individual
perspective of each dyad member rather than the “shared”
perspective, which can be important in contexts where the
patient and caregiver share in an experience together.12
Another study, by Taylor and deVocht (2011) suggests that
a limitation of interviews conducted jointly with both dyad
members is that, while it can offer the perspective shared
by both participants, the collected data does not
necessarily represent an “average” perspective of the
participants and similarly, the shared perspective cannot
necessarily be presumed from interviews conducted
individually. The authors therefore suggest using a dyad
approach when the goal of the research is to explore the
shared experiences among members of the dyad.15

Dyad approach in qualitative COA development
research

In standard practice, qualitative concept elicitation
interviews are commonly conducted with members of a
target patient population to identify the important and
relevant signs, symptoms, and impacts of a condition or its
treatment. Converging evidence from patient concept
elicitation interviews, meetings with clinical experts, and
the empirical literature informs the selection of concepts
to be measured in a COA. Once a COA has been selected
or developed, qualitative cognitive debriefing interviews
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are commonly conducted with members of the target
patient population to evaluate respondent ability to
understand and respond independently to questions.
In the context of concept elicitation interviews, the ISPOR
PRO Good Research Practices for the Assessment of Children and
Adolescents Task Force1 mentions dyad administration. While
the ISPOR Task Force’s general recommendation is for
pediatric concept elicitation interviews to be conducted
without a caregiver present, it recognizes that there are
“some context-specific exceptions to the recommendation
that child concept elicitation interviews be conducted
without a parent present” (p. 467). Matza et al (2013) note
that when researchers are interested in collecting the
shared perspective of patients and caregivers in a
questionnaire, “it may be useful to develop the
questionnaire based on dyadic rather than individual
concept elicitation interviews” (p. 467).1 The ISPOR Task
Force further acknowledges that there is “some support
for a parent-child dyad approach to assessment of the
child’s HRQOL, as opposed to the concept elicitation
phase of PRO instrument development” (p.467).1
While this approach has not been widely discussed, there
are examples in the empirical literature of COA qualitative
concept elicitation and cognitive debriefing interview
research involving a dyad approach to data collection.
For example, one recent study conducted qualitative
interviews16 with patient and caregiver dyads during the
development of a novel COA, the Life Interference
Questionnaire for Growth Hormone Deficiency (LIQGHD) (a modified version of the Injection Pen
Assessment Questionnaire, or IPAQ),17,18 to capture the
burden of long-term recombinant human growth hormone
(r-hGH) replacement therapy administered via daily
subcutaneous injections to treat growth hormone
deficiency (GHD) in children, adolescents, and adults. The
LIQ-GHD is novel as it includes several modules that can
be used depending on who is completing the
questionnaire. Specifically, the LIQ-GHD includes options
for child/caregiver dyad-report (e.g., on shared injection
administration experiences, such as those relating to pen
preparation, dose settings, injection, storage), self-report
(e.g., by children who independently manage their
injections), or caregiver-report (e.g., by caregivers who
manage all aspects of the injections for their child). For
dyad-report modules, the dyads were instructed to read
and answer questions together; however, the questions
could be completed independently by the patient or
caregiver given the wide target participant age range and
varied ability levels. Data are collected relating to
document “who reported” on the measure (i.e., the
patient, the caregiver, or both as a dyad). A module has
been included to allow patients 8-17 years of age to selfreport symptoms associated with injections, and a
caregiver-reported module assesses the injection-related
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signs for pediatric patients <8 years. There are also
caregiver-reported modules assessing the impact of daily
injections on the caregiver and family.
Though it has limitations, the LIQ-GHD may offer a
practical solution for the collection of treatment injection
experience data, given that the level of caregiver
involvement in the preparation and administration of
injections varies from dyad to dyad, and is not necessarily
dictated by the age of the patient.16 This dyad method of
data collection can be used to address challenges in
consistency of data collection in a clinical trial setting as
the approach recognizes that the characterization of the
treatment administration may not adequately be captured
by separate PRO and ObsRO measures and could result in
missing data on those questions not relevant to the
experience of the patient (on the PRO) or to the caregiver
(on the ObsRO), if one or the other has not been
responsible for certain tasks in the injection procedure.
As part of the broader LIQ-GHD development study,16
90-minute in-person combined concept elicitation and
cognitive debriefing qualitative interviews were conducted
with 15 patient/caregiver dyads. The patients were
children 4-12 years of age and adolescents 12-17 years of
age. During interviews, participants were first asked openended questions about the burden and impact of the
injection treatment. Questions were initially directed to the
pediatric patient; after the patient shared their perspective,
the interviewer prompted the caregiver to share any
additional comments. Some questions (e.g., symptom
experience) were asked only of the patient while other
questions (e.g., impacts on the caregiver and family life)
were asked only of the caregiver.
The second part of each interview focused on cognitive
debriefing of the draft LIQ-GHD, during which the
child/adolescent and caregiver participants were asked to
read the questionnaire and answer questions to support
evaluation of the tool’s relevance, comprehensiveness, and
comprehensibility. During cognitive debriefing,
participants were not provided instructions or guidance as
to which participant should respond to the question and
instead allowed the patient and caregiver to read the
instructions and choose which participant responded to
each question. Given the broad range of patient ages (4-15
years of age), and that the responsibilities for preparing
and administering the injections differed for each
patient/caregiver dyad, the way in which each pair read
and answered the questions varied. Overall, the content of
the LIQ-GHD core questions, relative to the age and
ability of patients, dictated who was able to respond to
each question. Findings indicated that generally, the
person or persons primarily responsible for the task
responded to the questions. If the patient completed the
task, the patient suggested the answer to the question or
led that discussion with the caregiver and vice versa. For
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example, caregivers were more likely to lead the discussion
on a reply to the question on the preparation and storage
of the injection pen if they were the dyad member
responsible for those tasks. When patients and caregivers
responded together to a question as a dyad, it took the
form of a negotiation and in this study no overt coercive
behavior (i.e., pressuring the child to change their reply)
was observed on the part of caregivers during the
interviews.
While results from this interview study were useful in
defining age limits for self-reporting on symptom
questions (ages 8 years and older), findings also suggest
that it is not appropriate to consider a single age-based
cut-off for the administration of questions to assess shared
injection experiences; for example, in this study, a 7 year
old managed injections and reported independently on the
experience, and two participants, ages 11 and 13 years,
managed injections together with their caregiver and
responded to questions in a dyad fashion (see Table 2).
In another example, Ungar et al (2006)19 conducted a joint
qualitative interview study that employed a “complete”
dyad approach involving 16 pediatric patients ages 8-15
years with asthma, and their primary caregiver, to
investigate a dyad approach when answering standardized
health-related quality of life (HRQOL) measures
developed for patient-reported administration. Two
disease-specific and two generic HRQOL PRO measures
were administered to pediatric patients and their
caregivers. The objective was to observe and describe the
interaction between the pediatric and caregiver dyads
during questionnaire completion. The approach employed
a dyad reporting “option.” While the introduction to the
questionnaire focused assessment by the child, the children
were also encouraged to ask the parent for help when
needed; likewise, the parent was instructed that they
intervene to assist their child when needed. The response
represents some combination of input from the child and
caregiver, a “shared response” that may contribute a
unique perspective beyond that which may be possible
through individual and separate reports from the child or
caregiver.
Findings suggest that parents were an important resource
to their child during completion, helping with issues
involving recall, response bias, frustration,
anxiety/discomfort, and comprehension; though the
authors report some evidence of parental coercion.
During the completion of questions, parents supported the
pediatric patient with the recall period by providing a
“bookmark” (specific reference point/event that happened
in the same timeframe) to help the child recall the time
period. Parents also supported the child in avoiding social
desirability bias (e.g., tendency to provide answers
expected to be socially desirable rather than the truthful
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Table 2. LIQ-GHD hybrid concept elicitation and cognitive debriefing using a dyad-report approach
Patient
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15

Age (years)
4
5
6
6
7
9
10
11
11
11
11
13
13
13
14

Primary CE Respondent
Caregiver
Dyad (patient and caregiver)
Dyad (patient and caregiver)
Dyad (patient and caregiver)
Dyad (patient and
Patient
caregiver)
Dyad (patient and caregiver)
Dyad (patient and caregiver)
Dyad (patient and caregiver)
Dyad (patient and caregiver)
Dyad (patient and caregiver)
Dyad (patient and caregiver)
Dyad (patient and caregiver)
Patient
Patient
Patient

response) by reminding and reassuring the child that they
can respond based on their experience (i.e., “there are no
right and wrong answers”) with no negative repercussions.
Parents identified moments of frustration on behalf of the
child (e.g., restlessness, disinterest) and suggested times
when the child may need a break.
While children were encouraged to answer questions, there
was discussion and negotiation for answers to questions
that occurred between the child and parent. However,
parental coercion/influence was observed to some degree
in 10 interviews as evidenced by the caregiver questioning
the accuracy of the child’s answer, encouraging the child to
reconsider their answer, pressing the child to answer
quickly when it was evident the child needed more time,
and/or silencing/redirecting the child. Instances of
coercion appeared to occur more in dyads with children
ages 8-10 years. Some participants also appeared to
answer a certain way to avoid perceived inter-relational
conflict. In this study, interviewers redirected questions to
the child participant to overcome parental coercion and
reminding the dyad that the interviewer was interested in
hearing the child’s perspective.
Some children expressed feelings of anxiety or discomfort
when asked questions about their past, present, or future
health state. As a strategy to address this issue, the parent
or interviewer assured the child that it was okay to answer
based on how they feel, or that they do not need to answer
at all. During the dyad interviews, parents were found to
play an important role as advocate and enabler including
the provision of additional information to the interviewer
and ensuring that the child was comfortable with the
interview process (advocacy) and encouraging the child to
answer based on their own feelings and perceptions,
translating questions into words that the parent knows the
child understands, and guiding the child through the
response options (enabling). Comprehension issues were
common, particularly among those 8-10 years old, and
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Primary CD Respondent
Caregiver
Dyad (patient and caregiver)
Caregiver
Dyad (patient and caregiver)
Dyad (patient and caregiver)
Dyad (patient and caregiver)
Dyad (patient and caregiver)
Patient
Patient
Patient
Dyad (patient and caregiver)
Patient
Patient
Patient

strategies used by the parent encouraged the child to ask
clarifying questions, to ask the interviewers to repeat a
question, or to explain the meaning of a questions or
words or phrases.
Ungar et al. noted that while parental coercion is an
important limitation to consider, it may be managed
through interviewer-administration of the COA with a
skilled facilitator using targeted redirection strategies.
Ungar et al also suggest that dyad questionnaire
administration may better capture “multi-factorial aspects
of paediatric HRQOL” than individual assessments of the
child or parent. These findings suggest that future studies
involving the administration of HRQOL measures to
dyads may benefit from interviewer-administration, which
provides the opportunity for clarification of instructions
and redirection when needed. The authors recommend
that findings from this interview study can be used to
inform the development of an interview guide to support
administration of HRQOL measures with child/parent
dyads.

Dyad report in quantitative research

Following best practices for questionnaire development,
after COA content has been evaluated in cognitive
debriefing research, the finalized version is administered to
participants as part of a quantitative study to enable the
analysis of item distributional properties, factor structure,
score psychometric performance (reliability, validity, ability
to detect change) and score interpretation (e.g., clinically
meaningful change). COAs can then be implemented in a
wide variety of research studies.
Currently there are a limited number of published studies
documenting the use of a dyad approach in quantitative
COA studies, and of those identified and summarized
below, the details describing administration procedures
vary by study.
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Coutant et al (2017)20 conducted a cross-sectional
observational survey study to evaluate the use of
SurePal™, a reusable self-injection system for use in
pediatric patients (ages 1-18 years) who have growth
disturbances. Approximately 57% of children completed
the questionnaire independently, while 43% had assistance
from another person (e.g., a family member). No details
are provided on the procedure utilized for shared
questionnaire completion among this latter child/caregiver
group. In this same study, half of the children prepared
the injection on their own, while nearly half had a family
member (47%) or nurse (2%) prepare the device for them.
Of those reporting, 44% of children performed the
injections themselves; 52% of children had a family
member perform the injection; and 2% had a nurse
perform the injection. The authors do not report instances
when injections were performed as a shared task between
the child and family member.
The IPAQ (pre-cursor to the prior described LIQ-GHD)18
was developed to assess child/adolescent (>8 and <18
years of age) and caregiver perceptions regarding ease of
use and preference for attributes of injection pens used to
administer daily injections of r-hGH.17,18 The IPAQ was
intended for completion by child/caregiver dyads as the
experiences and responsibilities associated with r-hGH
injection therapy (e.g., the injection process) are often
shared by children and their caregivers. Results reported in
the IPAQ psychometric evaluation study provide a
glimpse at these varied responsibilities, with the child
(17.6%), mother (64.0%), father (16.2%) or other caregiver
(2.1%) responsible for preparing the injection, and the
child (26.5%), mother (56.6%), father (15.4%), or other
caregiver (1.4%) responsible for administering the
injection.18 The developers suggest that a dyadic approach
is particularly useful in measuring activities that involve
high parent-child interaction and may help overcome
concordance issues that are sometimes found when
assessing the child and parent separately.18
As part of a US multicenter, open label study, Hey-Hadavi
et al (2010)21 collected data from 133 children ages 8-18
years currently being treated with r-hGH and their
caregivers using the IPAQ to assess ease of use and
preference for a new disposable r-hGH injection pen.
Here, one section of the IPAQ was administered at
baseline (assessing perceptions of the reusable pen) and
other components of the IPAQ were administered after
two months of using the new pen (assessing ease of use of
both pens, comparative ease of use of the two pens, and
pen preference). Specific instructions were provided to the
child and caregiver for how to work together when
completing the IPAQ. Dyads were asked to select a single
response to each question, agreed upon by both the parent
and caregiver. Any disagreement around what response to
select was to be resolved by the dyad with no intervention
from the study coordinators. In this study, most (82.4%)
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caregivers were the child’s mother, and in most cases the
caregivers were responsible for the preparation (82.0%)
and administration (72.9%) of the injections. 21
In research that quantitatively evaluated the LIQ-GHD (as
previously described), Turner-Bowker et al (2020)16
conducted an online, cross-sectional observational study to
test the tool’s hypothesized factor structure and score
reliability and validity in a sample of clinician-diagnosed
adult (>18 years) and pediatric (child [3-11 years] and
adolescent [12-17 years]) patients receiving daily r-hGH
injections for GHD. A total 224 patients participated ,
including 70 child/caregiver dyads, 79 adolescent/
caregiver dyads, and 75 adults. The child/adolescent dyad
version of the LIQ-GHD included questions for
completion by the child/adolescent only (e.g., sign and
symptom questions for self-report when >8 years of age);
questions for completion by the caregiver only (e.g.,
caregiver and family impact questions); and questions with
the option for dyad completion (e.g., treatment impact on
HRQOL; shared injection experience). For the dyad
administration, the patient and caregiver participants were
instructed to read and answer the questions together.
Results, reported for the overall sample and by age subgroup, demonstrated that the collection of quantitative
data using dyad administration is feasible and indicate that
the scores produced by the LIQ-GHD are reliable and
valid.
Extending upon initial qualitative research19 in this area,
Ungar et al (2012)22 evaluated the psychometric
performance of HRQOL and utility scores from measures
that used a parent-child dyad approach for data collection.
Specifically, data were collected from 91 child/adolescent
patients who have asthma and their caregivers via the
Health Utilities Index (HUI) 2 and 3, the Pediatric Quality
of Life Inventory™ (PedsQL™) Core and Asthma
modules, and the Pediatric Asthma Quality of Life
Questionnaire (PAQLQ) using a dyad approach. The
questionnaires were interviewer-administered to the dyad
with the interviewer serving as moderator, facilitating
dialogue between parent and child as they completed the
questionnaire and selected responses. This dyadic
approach, promoting discussion among members of the
dyad and clarifying perspectives, was described as one that
more closely resembles real-life communications. Two
interviewers were trained on the study instruments and
administered the HRQOL measures in a random order
between dyads (no counter-balancing within the dyad)
with questionnaires first administered by interviewers to
the parent and child separately, and immediately following
this, were then administered again but to the child and
parent together as a dyad. Cards with response options
printed on them were provided to the respondents.
Questions were read out loud and the respondent could
answer aloud or point to the selection on card. During the
dyad administration, one trained interviewer administered
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the questionnaires to the child and parent using an
interview guide. The interviewer encouraged the child and
parent to share their thoughts out loud as they considered
a response to a question; moderated to keep the discussion
on track; and validated comments using repetition of
words used by the child and/or parent. The interviewer
encouraged the child and parent to discuss the questions
together (rather than with the interviewer) and to resolve
disagreements by clarifying their respective perspectives,
although achieving consensus in perspectives was not
required. Only the child’s responses to the questions were
recorded. No differences were found between dyad and
independent administrations for the time to complete
questionnaires, and for the dyads, the time to complete
decreased over time.
Ungar et al described their perspectives on the advantages
and disadvantages of their approach. They noted that
since some younger children are still developing
cognitively, a parent can help in the elicitation of
preference data; help to “mitigate the confounding effect
of changing cognitive skills” (page 9); help a child’s recall
ability (bookmarking the recall timeframe to events in the
child’s life); and/or “lend some objectivity to observable
symptoms and behaviors in children of all ages” (e.g.,
noting, for example, that children may not know that what
they are experiencing are symptoms of a disease, or what
constitutes “normal” for a domain). Ungar et al also noted
that a parent’s presence can inhibit response bias or the
patient selecting the same response across multiple
questions (which can minimize missing or unreliable data)
and noted that the findings from their study demonstrate
the volume of missing data for the HUI decreased from
21% to 2%.
Ungar et al emphasize how their method (interviewing a
child and parent together) closely resembles how
information is obtained about a child’s health status in a
clinic setting. In terms of disadvantages, Ungar et al,
acknowledged that those serving in the role of interviewer
require special training to administer, facilitate, and
“ensure accurate capture of information” (p.10) and that
the child’s preferences may be influenced by the parent.
Noting how important it is for the young child’s voice to
be heard, they describe that “careful steps were taken to
mitigate bias or coercion by the parent and only the child’s
preferences and responses were recorded…[and] the
interviewer’s role as a facilitator will encourage expression
by the child” (p.10).

Discussion
A dyad reporting approach provides another option to be
considered in selected contexts that may enable the
collection of data representing a shared experience. Dyadreport may be a relevant approach to take when the
condition or treatment includes significant and shared
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involvement of the caregiver, and when events are
observable (such as in asthma management or injection
preparation and administration). Further, this approach
maybe be valuable when there are no specific age
thresholds for patient independence, as would be the case
of injection treatment administration, as it allows for
flexibility in the COA administration approach for each
individual dyad. In particular, the dyad approach may be
of value in a rare disease setting which frequently involves
pediatric populations, and the disease management may
involve a shared experience.
While in some cases caregivers may unduly influence a
child’s “voice” in the response, the involvement of a
caregiver as part of a dyad may offer important emotional
support to the child which would otherwise be lacking, if
only the child were the respondent, and may better reflect
a “real life” scenario in which patients and caregivers
engage in a dialogue. Acting as an advocate and enabler for
the pediatric participant during a dyad interview, the
caregiver may help provide context, resolve issues
involving recall, response bias, and frustration which may
occur. Importantly, comprehension issues may be
addressed by the caregiver reading question content aloud
when needed, encouraging the child to answer honestly, or
to explain the meaning of a question or specific words but
being careful not to paraphrase item content or coerce or
influence the child’s responses. The dialogue between
child and caregiver may result in less missing data, as
would be the case when a separate PRO and/or ObsRO
measure is administered with the intention of capturing
relevant aspects of a treatment experience. Depending on
the specific method used for data collection, a dyad option
may also limit and help to avoid unreliable proxy
reporting.
It should be noted that there are some contexts for which
a dyad approach should never be used. For instance, when
collecting subjective symptom severity data or the impact
of emotional functioning on the patient, because only the
patient can describe their experience of symptom severity
or emotions they are feeling. Additionally, the dyad
approach would not be suggested for use when collecting
data using questionnaires designed for completion by a
single party (i.e., patient- or caregiver-reported outcome
measures).
The inherent differential power dynamics in a caregiver/
patient relationship have been observed and can lead to
parental coercion or influence, either by imposing their
own views onto the child, by questioning the child’s
answer or pressing the child to answer the questions more
quickly than they would naturally. Ungar et al., observed
some evidence of coercion and recommended mitigating
the effects of potential caregiver coercion/influence (e.g.,
facilitation and re-direction of the dyad completion of a
questionnaire by a trained interviewer) that may be
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possible in some contexts. Whilst in theory, a trained
interviewer could facilitate a dyad-report approach to
questionnaire completion as described by Ungar et al. and
may even have the advantage of mimicking what occurs in
a clinic setting, caution is recommended with this
approach since it may not be practical to implement and
the involvement of an interviewer may be leading or may
unintentionally bias participant responses.
There are several recommendations to consider when
planning a dyad option for data collection as part of a
COA measurement strategy. First, consideration should be
made for the overall goals of measurement and the use of
a “complete” dyad approach (e.g., COA designed with the
intention for dyad-report on all questions) versus a dyad
reporting “option” (e.g., selected COA questions offering
a dyad, PRO, or ObsRO report option; qualitative
interview conducted intending to collect data from the
patient). It is important to consider the concepts being
assessed in the questionnaire when determining which
approach to take. For example, subjective internal
sensations such as pain or nausea should only be evaluated
by the patient as there is no way for the caregiver to truly
know what the patient is experiencing.
When providing respondents with a dyad reporting option,
it does beg the question “who reported on what” in the
single questionnaire. Therefore, it is recommended that
data should be collected on “who reported” (child alone,
caregiver alone, child/caregiver together) at questionnaire
and also ideally at the item level to enable sensitivity
analyses, if needed. Where possible, electronic data capture
should be used to facilitate the collection of these
additional data, and ease administration burden for
respondents.
During the dyad interaction, when the question and
response options are discussed by the patient-caregiver
pair, in instances where the caregiver must read
questionnaire instructions or item text aloud to the child,
instructions should be provided to remind the caregiver to
use caution in communicating with the child regarding the
question content (e.g., paraphrasing the question content is
not preferred and can change the meaning of the
question). The recommendation would be for the
questions be read verbatim and discussion to focus on an
appropriate response. In a questionnaire that contains
modules inviting patient self-report, caregiver-report, or
dyad-report options, instructions can be included to orient
the respondent accordingly.
Consistency in reporting is another important
consideration. In a clinical study setting, where dyad
reporting may occur at different timepoints, it is important
that the same caregiver be involved and reports at each
time period to provide consistency and minimize any
changes to the administration approach throughout the
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study. Further, setting expectations with each member of
the dyad and confirming what their role will be during
completion should be done ahead of implementation.

Conclusions
The dyad reporting approach has not been widely studied.
The research described here presents very few instances in
growth hormone treatment and asthma; however, it could
have a wider utility and application. While there are
limitations to a dyad approach, we have described its
application and shown it offers a pragmatic solution in
certain contexts, may help to avoid proxy report, and
minimize missing data. Dyad reporting has the potential to
positively or negatively impact overall data quality, and
when elected, should be used with intent, appropriate
instructions, and documentation, and should collect
sufficient administrative data for “who reports” to enable
sensitivity analyses, if needed. This approach offers
insights to the relational aspects of shared health
experiences and may yield more robust outcomes of the
treatment or condition. When there is a shared treatment
experience to be captured (beyond what may be measured
by a PRO or ObsRO alone), this approach provides
additional information to characterize the patient and
caregiver shared experience which is unique and may be
more comprehensive. It may be of particular value in rare
diseases, which disproportionally impact children and their
caregivers.
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